Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Emerg Microbes Infect
Autors principals: Zhang, Ya-Nan, Zhang, Qiu-Yan, Li, Xiao-Dan, Xiong, Jin, Xiao, Shu-Qi, Wang, Zhen, Zhang, Zhe-Rui, Deng, Cheng-Lin, Yang, Xing-Lou, Wei, Hong-Ping, Yuan, Zhi-Ming, Ye, Han-Qing, Zhang, Bo
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Letter
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448857/
https://ncbi.nlm.nih.gov/pubmed/32432977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1772676
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars